Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Heart Test Laboratories, Inc. ( (HSCS) ) has issued an update.
HeartSciences Inc. recently filed an Offering Statement with the SEC, which was qualified on March 10, 2025, to register the offering of up to 4,285,714 units at $3.50 per unit, aiming to raise a maximum of $15,000,000. The company entered into a Selling Agency Agreement with Digital Offering, LLC, as the sole placement agent for this offering. On May 28, 2025, HeartSciences was informed by the Texas Secretary of State that its Certificate of Designations for Series D Convertible Preferred Stock was filed, effective May 21, 2025, designating 4,285,714 shares of preferred stock.
The most recent analyst rating on (HSCS) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Heart Test Laboratories, Inc. stock, see the HSCS Stock Forecast page.
Spark’s Take on HSCS Stock
According to Spark, TipRanks’ AI Analyst, HSCS is a Neutral.
The overall score is primarily impacted by the company’s weak financial performance and challenging valuation, indicating significant financial instability. Technical analysis provides some positive signals but is not sufficient to offset the financial concerns.
To see Spark’s full report on HSCS stock, click here.
More about Heart Test Laboratories, Inc.
Average Trading Volume: 16,821
Technical Sentiment Signal: Sell
Current Market Cap: $3.99M
Find detailed analytics on HSCS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue